Peter Boström

Integrins are enriched on aberrantly fucosylated tumour‐derived urinary extracellular vesicles (2022)

Islam Md. Khirul, Dhondt Bert, Syed Parvez, Khan Misba, Gidwani Kamlesh, Webber Jason, Hendrix An, Jenster Guido, Lamminen Tarja, Boström Peter J, Pettersson Kim, Lamminmäki Urpo, Leivo Janne

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Incidence of and mortality from Bacille Calmette-Guerin (BCG) infections after BCG instillation therapy (2022)

BJU International

Nurminen Pertti, Ettala Otto, Uusitalo-Seppälä Raija, Nummi Antti, Järvinen Riikka, Antti Kaipia, Boström Peter J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer (2022)

Nuclear Medicine Communications

Arvola Samuli, Seppänen Marko, Malaspina Simona, Mätzke Sorjo, Raiko Juho, Timonen Kirsi L, Ettala Otto, Jambor Ivar, Anttinen Mikael, Kuisma Anna, Löyttyniemi Eliisa, Boström Peter J, Sohlberg Antti, Noponen Tommi

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator (2022)

European Urology Open Science

Parekh Sneha, Ratnani Parita, Falagario Ugo, Lundon Dara, Kewlani Deepshikha, Nasri Jordan, Dovey Zach, Stroumbakis Dimitrios, Ranti Daniel, Grauer Ralph, Sobotka Stanislaw, Pedraza Adriana, Wagaskar Vinayak, Mistry Lajja, Jambor Ivan, Lantz Anna, Ettala Otto, Stabile Armando, Taimen Pekka, Aronen Hannu J, Knaapila Juha, Perez Ileana Montoya, Gandaglia Giorgio, Martini Alberto, Picker Wolfgang, Haug Erik, Cormio Luigi, Nordström Tobias, Briganti Alberto, Boström Peter J, Carrieri Giuseppe, Haines Kenneth, Gorin Michael A, Wiklund Peter, Menon Mani, Tewari Ash

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy (2022)

Biomedical Engineering Letters

Wright Cameron, Mäkelä Pietari, Bigot Alexandre, Anttinen Mikael, Boström Peter J., Blanco Sequeiros Blanco

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)

Human Molecular Genetics

Wahlström Gudrun, Heron Samuel, Knuuttila Matias, Kaikkonen Elina, Tulonen Nea, Metsälä Olli, Lof Christoffer, Ettala Otto, Boström Peter J., Taimen Pekka, Poutanen Matti, Schleutker Johanna

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study (2022)

World Journal of Urology

Salmivalli Alisa, Ettala Otto, Boström Peter J, Kytö Ville

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019 (2022)

Acta Oncologica

Seikkula Heikki, Kaipia Antti, Boström Peter J., Malila Nea, Pitkäniemi Janne, Seppä Karri

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Detection of prostate cancer bone metastases with fast whole-body Tc-99m-HMDP SPECT/CT using a general-purpose CZT system (2022)

EJNMMI Physics

Arvola Samuli, Seppänen Marko, Timonen Kirsi L, Rautio Pentti, Ettala Otto, Anttinen Mikael, Boström Peter J, Noponen Tommi

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)

BMJ Open

Ettala Otto, Jambor Ivan, Perez Ileana Montoya, Seppänen Marjo, Kaipia Antti, Seikkula Heikki, Syvänen Kari T, Taimen Pekka, Verho Janne, Steiner Aida, Saunavaara Jani, Saukko Ekaterina, Löyttyniemi Eliisa, Sjoberg Daniel D, Vickers Andrew, Aronen Hannu, Boström Peter

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Publications

Sort by:

Integrins are enriched on aberrantly fucosylated tumour‐derived urinary extracellular vesicles (2022)

Incidence of and mortality from Bacille Calmette-Guerin (BCG) infections after BCG instillation therapy (2022)

Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer (2022)

Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy (2022)

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)

Mortality after surgery for benign prostate hyperplasia: a nationwide cohort study (2022)

Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019 (2022)

Detection of prostate cancer bone metastases with fast whole-body Tc-99m-HMDP SPECT/CT using a general-purpose CZT system (2022)

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)